INOVIO PHARMACEUTICALS, INC.·4

May 21, 4:06 PM ET

DANSEY ROGER D 4

Research Summary

AI-generated summary

Updated

Inovio (INO) Director Roger Dansey Receives Equity Awards

What Happened

  • Director Roger Dansey was granted a total of 76,000 equity awards on 2026-05-20: 41,800 option-based awards (derivative) and 34,200 restricted stock units (RSUs). Both grants show an acquisition price of $0.00 (typical for compensation awards) and therefore no immediate cash value reported in the filing.

Key Details

  • Transaction date: 2026-05-20; Form 4 filed: 2026-05-21 (timely).
  • Grants: 41,800 derivative awards (options) @ $0.00; 34,200 RSUs @ $0.00. Total awarded shares: 76,000.
  • Vesting: Options vest 100% on May 20, 2027 (F2). RSUs vest 100% on May 20, 2027 and each RSU converts to one share upon vesting (F3).
  • Plan and policy: Awards granted under the 2023 Omnibus Incentive Plan per the issuer’s non-employee director compensation policy (F1).
  • Shares owned after transaction: Not specified in the filing.

Context

  • These awards are compensation grants to a non-employee director, not an open-market purchase or sale. Options and RSUs are deferred/contingent compensation that vest in one year; they do not represent immediate cash proceeds and do not necessarily indicate short-term trading intent. Grants under director comp policies are common and routine.